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SUMMARY 
Although adenosine is known to activate K+ conduction in atrial 
tissue, there is stl debate as to the involvement of cAMP-
dapendent mechanisms. ln isolated adult guinea pig atrial myo-
cytes, we demonstrate that the highly A,-selective adenosine 
receptor agonist 2-chloro-N'-cyclopentytadenosine reduoed 
basal cAMP Ieveis by 30-40% in the absence and presence of 
the nonxanthine phosphodlesterase Inhibitor Ro 20-1724. lso-
prenaline caused a concentration-dependent increase in cAMP 
Ieveis, whlch was more pronounced in the presence of the 
phosphodiesterase Inhibitor. Several adenosine derivatives sup-
pressed the isoprenaline-induoed cAMP increase by approxi-
mately SOOk. The rank order of potency was 2-chloro-N'-cyclo-
pentyfadenosine (ICac,, 93 nM) > (R)-N'-phenyllsopropyladenosi 
(ICso, 309 nM) > 5' -N-ethylcarboxamidoadenosine (IC110, 813 nM) 
:::. (S)-N'-phenyllsopropyladenosine (IC110, 26,300 nM). A simllar 
Adenosine has a number of cardiac effects, which generally 
are inhibitory. In ventricular tissue, it has little direct effect on 
contractility or electrical activity, but it antagonizes positive 
inotropic effects elicited by cAMP-increasing agents (1-3). The 
ionic basis for these indirect adenosine actions has been pro-
posed tobe a decrease in catecholamine-stimulated Ca2+ con-
ductance (4, 5). Controversial findinga have been made con-
ceming the contribution of changes in adenylate cyclase activ-
ity to these effects, i.e., stimulation (6), no effect (3), or 
inhibition (7). However, it has been shown in ventricular myo-
cytes that the cAMP increase induced by compounds such as 
isoprenaHne and forskolin, which enhance the activity of aden-
ylate cyclase, is reduced by several adenosine derivatives (8-
11). 
In the atrium, adenosine exerts direct inhibitory effects, 
which are suggested tobe mediated by A1-adenosine receptors 
Thia study wu aupported by tbe Deut.cbe Foi'IIChUJlPPmeinacbaft. 
but complete suppression of the isoprenaline-induced cAMP 
increase was produced by the muscarinic receptor agonist car-
bachol (ICao. 398 nM), which like adenosine is known to activate 
atrial K+ channels. The A,-adenosine receptor-selective antago-
nist 8-cyclopentyl-1,3-dipropylxanthine antagonized the effect of 
2-dlloroN'-cyclopentyladenoslne concentratlon-dependently, 
with a Ks value of 9.6 nM. ln atrial myocytes isolated from guinea 
pigs pretreated with pertussls toxin, the inhibitory effects of 
adenosine analogs on basal and isoprenaJine-stimulated cAMP 
accumulation were markedly attenuated. lt is concluded that the 
adenosine receptor in guinea pig atrial myocytes, which is known 
to be linked to K+ channels, is also couplad to adenylate cyclase 
via a pertussis toxin-sensitive guanine nucleotide-binding protein 
and shows the characteristics of the A,-adenoslne receptor 
subtype. 
(12-14). Regarding the underlying mechanism, major impor-
tance has been ascribed to the role of K+ channels. In atrial 
myocytes, adenosine increases a K+ conductance of the cell 
membrane (15-17), causing hyperpolarization ~d, hence, 
shortening of the action potential duration. This effect is 
mediatedvia a GTP-dependent regulatory proteinthat is in-
hibited by pertussis toxin (18). 
Although A1 receptors appear to mediate the negative ino-
tropic effects of adenosine in atrial tissue, it is still subject to 
debate whether changes in adenylate cyclase activity are in-
volved. While Endoh et al. (19) reported that in atrial prepa-
rations the antagonism by adenosine of ß-adrenergic effects 
was accompanied by decreases in elevated cAMP Ievels, others 
failed to observe concomitant reductions of cAMP content (3, 
20). 
These divergent results might be related to the cellular 
heterogeneity of cardiac tissue. Tberefore, we used a unicellular 
preparation of guinea pig atria and studied the inhibitory effects 
A88REVIATIONS: PIA, 1J8-phenyllsopropyladenoslne; CCPA, 2~-cyclopentytadenosine; DPCPX, 8-cyclopentyl-1,3-dlpropylxanth; 
HEPES, N-2-hydroxyethylpiperazjne-N-2«hanesulfonlc add; NECA, 5' -N~xamidoadenosine; Ro 20-1724, 4-(3-butoxy-4-methoxybenzyl)-
2-knldazolldlnone; ScAMPTME. 2' -0-monosuccinyladenosine-3' ,5' -cyclic monophoaphate tyrosyl methyl ester; EGTA, ethylene glycol ~ 
ethyt ethar}N .N.N' .N' -tetraacaUc add; G protein, guannt nuclaoUde-blndi protein. 
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of different adenosine analogs on cAMP Ievels in isolated adult 
guinea pig atrial myocytes. Furthermore, we emmined the 
effect of a pretreatment with pertussis toxin on the action of 
the adenosine derivatives. 
Experimental Procedures 
Materiala. Carrier-free Na1211 was purchased from Amersbam-
Bucbler (Braunacbweig, FRG). Adenosine deaminaae (200 units/mg), 
(R)-PIA, (8)-PIA, and NECA were obtained from Boebringer Mann-
beim GmbH (Mannheim, FRG). DPCPX and CCPA were ayntbeaized 
according to the metbod of Lohae et al. (21, 22). Ro 20-1724 was a gift 
from Dr. W. E. Scott (Hoffmann-La Rocbe, Nutley, NJ). laoprenaline, 
ScAMPTME, bovine aerum albumin fraction V, crude collagenase 
(C2139), deoxyribonucleaae I, proteasetype XIV, and pertuuia toxin 
(ialet-activating protein) were from Sigma (Deiaenbofen, FRG ). Elas-
tase 20931 wu purcbaaed from Serva (Heidelberg, FRG). All cbemicala 
were of analytical pade or tbe beet commercial grade available. 
Preparatioa of 1•1-ScAMPTME. 1211-ScAMPTME was prepared 
by tbe chloramine-T metbod (23), and tbe reaction product was aepa-
rated by ael filtration on Sepbadex G-25 auperfine and stored at -25·. 
&olatioa of atrial myocyteL Atrial myocytea were iaolated from 
bearts of adult male guinea pip (300-350 g). For aome experiments, 
pinea pip were pretreated witb pertuaais toxin (180 1'1/kg intrave-
noualy) 27 br before the uperiments, during brief etber aneatbeaia. 
Control anima.le were treated in tbe aame way witb tbe aolvent alone 
(aodium pboephate, pH 7.5, 0.5 Y NaCl; 750 ,d/100 g of body weigbt). 
Diapersed 1trial ceU. wen obtained according to tbe metbod of Becbem 
et al. (24), with minor modificationa. Tbe animala were injected witb 
500 unita of aodium beparin intraperitoneally and killed 20 min later 
by a blow on the neck. They were bled from tbe carotid arteries, and 
tbe hearta were rapidly uciaed and mounted on a cannula of 1 Lan-
pndorff perfuaion syatem. The ilolated bearts were perfuaed for 5-10 
min, at a preaaure of 50 cm of w1ter, witb a calcium-free perfusion 
aolution (solution A) consisting of (mY): NaCI, 140; KCl, 5.4; MgClz, 
1.0; glucoee, 5.0; and HEPES-NaOH, 10; pH 7.4, whicb was continu-
oualy gasaed witb 0 1 and maintained 1t 37•. All following steps were 
clone at 37•. Tbe bearta were subeequently perfused in 1 recirculating 
manner witb a eolution of tbe aame compoeition containing 0.5 mM 
EGTA and aupplemented with collapnue (1 mc/ml), elastase (10 ,al 
of 8U8peDSion/ml), deosyribonucleaae (0.3 mgjml), protease (0.1 mgJ 
ml), and bovine serum albumin (0.5 mgjml). After 20 min, tbe bearta 
were removed from tbe perfuaion apparatua and tbe atria were trans-
ferred into Petri diabea containing 2 ml of aolution A witb added bovine 
aerum albumin (0.5 mg/ml) and deoxyribonuclease (0.3 mg/ml). Tbe 
1tria were cut iDto tbree or four piecea and diaeolved by pntly moving 
tbe piecee of tiaaue tbrougb tbe aolution. Tbe resulting cell suapenaion 
was tranaferred into aolution A and paued tbrougb 150-1&111 mesb nylon 
puze. Calcium was gradually increased to 1.0 mu. Myocyte yield (about 
1.2 x 1o- ceUa/heart) and viability (about 65-80%) were determined by 
microacopic e:umination. Noncardiomyocyte cell contributiona were 
negligible. Cella were conaidered viable when tbey were spindle-sbaped 
TASLE 1 
lhct of ............ CCPA, Md Ao •1724 on cAIII' levela of 
leolaled ..... plg ....... myocytn 
cAMP Wl8 ~ after 15-m lncubation of myocytes wlth adenollne daen'lt-
... (0.5 ldafml) InS the lndlcated adcltlons. Data .. ~ ± 8tlnMrd .-rors 
of lix exper'.nw~ts. 
None 
CCPA(1 ~&M) 
lsoprenallne (1 p.M) 
+ CCPA (1 I&M) 
Control + Ro 2().1724 (0.5 11'111) 
pmd/10' call 
7.1 ± 1.2 11.8 ± 1 .0 
4.2 ± o.s• 8.4 ± o.g• 
25.5 ± 2.7 62.7 ± 3.7 
8.6 ± 1.4• 22.0 ± 2.6• 
• p < 0.05 vei"'IU8 p~eceedlug va1ue (t test). 
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CONCENTRATION OF ISOPRENALINE lmol/1) 
Flg. 1. Effect of isoprenahJ on cAMP Ieveis of guinea pig atrial myocytes. 
The cAMP content was measured 15 mr. after additlon of incr8as6ng 
ooucentrations of isoprenallne, 1n the preaence of Ro 20-1724 (0.5 mM) 
and adenoslne dean'W1ase (0.5 unlts/ml). 88 descrtbad in Experimental 
Procedlns. The basal Y8lue was 8.4 ± 2.8 pmol of cAMP/1o- cels. 
Values .-e me~nS ± standard errors of ttne exper'.ments. 
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Flg. 2. rme oourse of the effects of lsoprenaline and CCPA on cAMP 
Ieveis. Myocytes were incubated either in the abaenoe (0) M in the 
presence (e) of 1 11M lsoprenaline. The basal value was 14.0 pmol of 
cAMP/1 0' cels. After 5 m, CCPA (1 I&M) was added to the lsoprenallne-
stimulated ce1s ~· Data .-e from one rap asentative expertment. 
or beginning to round up but sbowed no blebs or granulation. laolated 
atrial myocytea remained viable for at least 60 min in aolution A 
supplemented witb bovine aerum albumin and deoxyribonucleaae. 
Meuuremeat of cAMP. cAMP content of fresbly iaolated 1trial 
myocytea (7,000-10,000 cella/tube) was measured at 37• in 1 total 
volume of 100 ,al of aolution A (pH 7.4) supplemented witb 1.0 mM 
CaCiz. Subetancea routinely added were 0.5 unita/ml adenoaine deam-
inaae to remove endogeneous adenoaine, 0.5 mY Ro 20-1724 to inbibit 
pbospbodieaterase activity, and 1 ,aY isoprenaline to stimulate cAMP 
formation. Tbe incubation was atarted by tbe addition of 70 ,d of tbe 
cell 8U8penaion and was terminated after 15 min by tbe addition of 900 
,d of 0.2 M &Odium acetate buffer (95•; pH 6.0). cAMP was determined 
by a sensitive radioimmunoassay, using 1211-ScAMPTME as labeled 
tracer (25). 
Data analyaia. Concentration-responae curvea were fitted to tbe 
Hill equation by a nonweigbted nonlinear curve-fitting program, aa 
deacribed earlier (26). 
Results 
Incubation of isolated adult guinea pig atrial myocytes with 
1 #'M CCPA resulted in a 40% decrease in basal cAMP Ievels 
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CONCENTRATION OF AGONIST lmol/ll 
Flg. 3. Etfect of adanosine analog& on cAMP Ieveis of guinee pig atrial 
myocytes. Myocytes were lncubated wtth 1 ~&M isopranaltne and lncreas-
ing COIIOIIItnltlons of CCPA (e), (R)-PIA •• NECA (.). ar (S)-PIA (A), 
for 15 mWI. The baSII value (mean ± standard error) was 11.6 ± 3.2 
pmol of cAMP/10" oalls. Data are means of four experimants. 
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CONCENTRATION OF CCPA lmol/ll 
Flg. 4. Effect of the 8denoelne antagonlat DPCPX on the CCPA-induoed 
reduction of cAMP Ieveis in gulnea pig atrtel myocytes. cAMP Ieveis were 
raiaed by 1 I'M l8oprenallne. The basal value (mean ± standard arror) 
wu 9.6 ± 2.5 pmol of cAMP/10" cell. Myocytes were lncubatad for 15 
mWI before the cAMP contant was rneutnd as descrtbed in Expertmen-
tal Prooadl.nl. The etrect of CCPA was examNd in the absence (e) 
n in the preaence of 10 nu ~. 100 nu (.). n 1000 nu (II) DPCPX. 
,"..,, Schild plot of the data. C, COIIOinlnltion of DPCPX (in M); CR, ratio 
of the 1Ceo va1ues of CCPA in the p8811108 and absenOa of DPCPX. Data 
are ,_.,. of ttne expertmenta. 
(Table 1). Ieoprenaline (1 I'M) cauaed a 3-fold increase in cAMP 
ccmtent, which was almoat completely suppressed by 1 I'M 
CCPA. 
In the preaence of the nonxanthine phoaphodiesteraae inhib-
itor Ro 20-1124 (0.5 mM), basal cAMP Ievels were elevated by 
70%. Under these conditions, 1 I'M CCPA produced a 30% 
reduction in basal cAMP Ievels, whereaa 1 I'M iaoprenaline 
induced an almost 6-fold increase in cAMP accumulation (Ta-
ble 1). CCPA (1 ~tM) reduced ieoprenaline-enhanced cAMP 
Ievels by 80%. The ieoprenaline-induced cAMP increase was 
larpr in the preaence of the phoaphodiesterase inhibitor, and 
the inhibitory effect of CCPA was more eaaily detectable. 
Therefore, aß other es.perimenta were performed in the prea-
ence of 0.5 mM Ro 20-1724. 
Fig. 1 showa the concentration-reaponse curve for ieoprena-
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CONCENTRATION OF CARBACHOL lmol/ll 
Flg. 5. Effect of carb8chol on cAMP Ieveis of guinea plg atrtal myocytes. 
cAMP Ieveis were enhenoad by 1 I'M lsqnrlllline. The basal value (rn.n 
± standlrd enor) was 11.8 ± 1. 7 pmol of cAMP/1 OS celll. Myocytea 
were lncubatad for 15 m1n betont the cAMP contant was meutnd u 
descrtbed in Expertmental Procedures. Data are rneena of ttne experi-
ments. 
line. The maximally effective concentration of ieoprenaline (1 
pM) produced a pronounced increase in cAMP Ievels. The ECao 
value for thia effect was 37 nM. 
A time coune of the effects of iaoprenaline U~tM) and CCPA 
(1pM) on cAMP formation is illustrated in Fig. 2. The rise in 
cAMP was rapid, beingabout 4-fold alter 1 min and maximal 
alter 5 min. Addition of the adenosine receptor agonist CCPA 
reaulted in a rapid decreaae of ieoprenaline-stimulated cAMP 
Ievels. 
The following set of es.perimenta was done to study the effecta 
of various adenosine derivatives on ieoprenaline-atimulated 
cAMP formation. In Fig. 3, the concentration-response curves 
for agonista are ahown. All agonista reduced cAMP Ievels in a 
concentration-dependent manner. CCPA was the mostpotent 
agonist, with an ICao value of 93 nM, beingabout 3-fold more 
potent than (R)-PIA and about 9-fold morepotent than NECA 
(Table 2). (R)-PIA was about 85 times more potent than (S)-
PIA in reducing the ieoprenaline-mediated cAMP increaae 
(Table 2), indicating the stereoapecific action of the PIA dias-
tereomers. 
The intluence of pertussis toxin on the effecta of adenosine 
analop on basal and ieoprenaline-atimulated cAMP accumu-
lation is shown in Table 3. The reduction of basal cAMP Ievels 
by CCPA was abolished by pretreatment of guinea pip with 
pertussis toxin before the ieolation of atrial myocytes. The 
inhibitory effects of several adenosine derivatives on ieopren-
aline-induced cAMP increases were partially reversed by pre-
treatment with pertussis toxin. 
The At receptor-aelective antagoniat DPCPX reversed the 
inhibitory effect of CCPA (Fig. 4). DPCPX shifted the concen-
tration-response curve of CCPA to the right, in a concentration-
dependent manner. A Schildplot of the data gave a line with a 
slope near unity and a Ks value of 9.6 nM. leoprenaline-
stimulated cAMP Ievels were not substantially altered by 
DPCPX, confirm.ing that DPCPX has no inhibitory effect on 
phosphodiesterase activity (21). 
Furthermore, the effect of the musearlnie receptor agonist 
carbachol on the cAMP content of guinea pig atrial myocytes 
was examined (Fig. 5). The ieoprenaline-elevated cAMP Ievels 
were reduced in a concentration-dependent manner, with a 
TABLE2 
ltfecl of different lidenGeine .............. muecartnlc ....... 
...-.~an cAW IICCUIIIUIIItlo ln ..,._ plg....., 
IIIJ'OCY1IH, an the blndlng of ['H]DPCPX to ....... plg ..,... 
.......... ..., 8lld an "Rb• etflux nilein lloiMed left gulnM plg atrta 
V..._~ .. geonwtrtc .,_,. d ttne to 11x exper'•••ltl. The 95% 
COii3deiiCit llmlls ... glven ln Pll•iltlelll. 
n11 
CCPA 93 (57-154) 1.2- 82• 103• (37 -290) 
(R)-PIA _. (245-389) 1.4• &1· 137• (85-222) 
NECA 813.(582-1.202) 1.8• ee• 217• (157-301) 
(S)-PIA 28,:JOO- 331.()- 1,788• 12,905• 
(17,378-41,888) (8,338-28,288) 
Clrbachol 388 (133-1,183) NO• NO ND 
• Data from Ref. 29. 
• p < 0.05 .... pr8CIIdlilg IUb8tW'Ice (t tast). 
• NO, not deten'*lld. 
TABLE3 
....._of ...,.....tDJdn an .. eflecl8otleoprel•• 8nd 
clfferMIIIdel ................. cAW ..... ot ................. plg 
8IIIIIIIIIJOCJtM 
Anmlll were pr8lr-.lld wllh pertullll tox1n 01 the ea1vw1t IIane, • dllatbed in 
Elcpe(••-111 ~. cAMP W8l ~.,.. 15-mln lncubetlon ol ~ 
cyl8l wltti lldlnCIIIne dllmll- (0.5 &nla/ml), Ro 20-1724 (0.5 mM), ll'ld the 
lndlcated adcltlanl. Data .. ",_. ± standlrd emn d ttne expertments. 
None 
CCPA (1 0 ,.u) 
l8oprw1allne (1 p.M) 
+ CCPA (10 11M) 
+(R~(10p.M) 
+ NECA (10 11M) 
+ (S)-PIA (300 11M) 
cNif' 
pmq~J1ae• 
1 ..... ± 3.7 1 ... 9 ± ... 1 
9.5 ± 2.5 16.3 ± 1.6 1.-.o ± 2.1 69.6 ± 8.8 
16.8 ± 0.7• 32 ... ± 2.9• 
22.8 ± o.6• 39.3 ± .-.e• 
22.1 ± 0.9• 38.0 ± 3.3• 
28.3 ± o . .-· ..a.2 ± .-.1 
• p < 0.05 _.. COIIeepaiidilg leop•~ Vllue (t tast). 
half-maximal inhibition at a concentration of 398 nM (Table 
2). Maximally effective concentrationa of carbachol completely 
euppreaaed iloprenaline-stimulated cAMP levela. 
Dlscussion 
Similar to earlier studies with ventricular myocytes, the 
present study showa that, in guinea pig atrial myocytes, differ-
ent adenoaine analop cauaed concentration-dependent de-
creues in iaoprenaline-stimulated cAMP Ievels. 
In atrial myocytee, two major findinp were obtained sug-
psting the involvement of an A1 adenosine receptor in the 
mediation of theee effects. Firstly, the rank order of potency 
for adenoeine analop was CCPA > (R)-PIA > NECA:::. (S)-
PIA. Thua, including the marked stereoselectivity between (R)-
and (S)-PIA, it cloeely resembles the pharmacological profile 
of cardiac A. receptors described in ventricular preparations. 
Thia haa been demonatrated in functional studies on the inhi-
bition of cAMP accumulation in rat ventricular myocytes (10, 
11) and in radiolipnd binding esperiments in bovine myocar-
dium (27) or in rat ventricular myocytes (28). Secondly, the 
inhibitory effect of the adenoaine derivatives on iaoprenaline-
stimulated cAMP accumulation in atrial myocytes was antag-
onized by the A. receptor-selective antagonist DPCPX. 
CMnlctertzatlon of AtrW AdeiiOIII• Receptor 919 
The agonist profile in this study differs somewhat from our 
recent report (29), which, by means of IIJlb• emux measure-
ments, demonstrated a K• channel-coupled adenosine receptor 
of the A1 receptor family in guinea pig atria. Contrary to the 
present work, only small differences in the potencies of CCPA, 
(R)-PIA, and NECA were observed (Table 2). In radioligand 
binding studies, these differences were virtually absent, because 
almost identical Ki values for the qonists were obtained (Table 
2). The reason for this discrepancy remains tobe elucidated. 
One possibility is a heterogeneity of A. receptors, although the 
results obtained in binding esperiments do not favor this hy-
pothesis. Another explanation for the divergent results would 
be that two different G proteina are involved in the atrial 
effects of adenosine, which are coupled to a homogeneoua A1 
receptor population. The G proteina involved in these proc-
esses, mediating the activation of K+ channela and the inhibi-
tion of adenylate cyclase activity, have been termed Gx and G" 
respectively. Their identities remain tobe established (30). lt 
is even unknown whether G~~: and G1 represent distinct G 
proteins. Recently, it has been reported that G1 subunits bad 
~ activity in guinea pig atrial cella (31). Previoualy, it has been 
demonstrated that pertuaais toxin-sensitive G proteina are in-
volved in the activation of K+ channela in guinea pig atrial 
myocytes (18). Similarly, the present results indicate the exist-
ence of a pertuaais toxin-sensitive G protein that mediates the 
inhibitory effects of the atrial A1 receptor on adenylate cyclase 
activity. Yet, it cannot be distinguished at present whether the 
above-mentioned differences in the pharmacological profiles of 
atrial A1-adenosine receptors are due to a heterogeneity of A. 
receptors, G proteins, or the involvement of additional factors. 
Inconsistent results have been obtained in previoua studies 
on the effect of adenosine on cAMP Ievels in iaolated atria (3, 
19, 20). The interpretation of these results might be compli-
cated by the fact that iaolated atria contain a miiture of cell 
type&. An A. receptor-mediated decrease of cAMP in myocytes 
might, therefore, be masked by a concomitant activation of Az 
receptors of endothelial cella (32). By the use of isolated atrial 
myocytes, the disadvantapa of whole organ preparations can 
be excluded. 
Additional support for the aasumption that atrial adenoaine 
receptors are of the A. subtype has been provided recently. 
Radioligand binding studies showed the presence of an A1-
adenosine receptor in porcine atrium (33, 34). Furthermore, in 
cultured embryonie chick atrial myocytes, the existence of Al-
adenosine receptors, which are coupled to adenylate cyclase 
and to the contractile state in an inhibitory pertuaais toxin-
sensitive manner, was demonstrated. (35). Thia atudy also 
showed that adenosine analop were capable of inhibiting both 
the basal and iaoprenaline-stimulated adenylate cyclase activ-
ity, although the extent of the inhibitory effect was much less 
than in the present study. In all of the studies cited, somewhat 
different agonist profiles were obtained but the involvement of 
the A. receptor subtype was suggested, because the highly A.-
selective antagonist DPCPX showed the espected properties. 
lt should be considered that deviations from the prototypical 
A. profile for agonists might partly be due to species differences. 
The extent of inhibition of iaoprenaline-induced cAMP ac-
cumulation by adenosine was different in atrial and ventricular 
cellular preparationa. In our present study on guinea pig atrial 
myocytes, adenosine analop caused a marked reduction (80-
90%) of iloprenaline-stimulated cAMP formation, whereas in 
' 
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rat ventricular myocytes (10, 11) andin guinea pig ventricular 
myocytes (36) only a 4:0-50% inhibition of isoprenaline-en-
hanced cAMP content was observed. This difference in efficacy 
may be explained by a higher adenosine receptor density in 
atrial than in ventricular myocardium (14, 37). 
lt is generally accepted that adenosine and acetylcholine 
exert similar actions via different receptors but common mech-
anisms. These include Stimulation of K+ conductance (15, 18, 
38) and inhibition of adenylate cyclase (39, 4:0). Thus, in 
comparison with adenosine analogs, the musearlnie receptor 
agonist carbachol showed a similar but even more effective 
inhibition of isoprenaline-stimulated cAMP accumulation. The 
greater efficacy of carbachol might be related to the greater 
density of musearlnie receptors than adenosine receptors in 
atrial tiuue (37). 
In summary, our results suggest that the adenylate cyclase-
coupled adenosine receptor present in isolated adult guinea pig 
atrial myocytes has the characteristics of the A1 subtype. To-
gether with the data from previous studies, atrial adenosine 
receptors in guinea pig heart appear tobe linked to K+ channels, 
as well as to adenylate cyclase, in a pertussis toxin-sensitive 
manner. 
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